Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S DiPaola

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
To arrest or not to G(2)-M Cell-cycle arrest : commentary re: A. K. Tyagi et al., Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G(2)-M arrest, and apoptosis. Clin. cancer res., 8: 3512-3519, 2002Robert S DiPaola
Transactions of the American Clinical and Climatological Association|August 7, 2025
LEADING A TRANSDISCIPLINARY TEAM MODEL ACROSS A COMPREHENSIVE CAMPUSRobert S Dipaola
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Clinical research in metastatic prostate cancer: a focus on impact and valueMaha Hussain, Robert S DiPaola
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
The double-edged sword of autophagy modulation in cancerEileen White, Robert S DiPaola
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Cabozantinib in prostate cancer: the beginning of a precision paradigm?Susan Goodin, Robert S DiPaola
Urology|May 12, 2005
National cooperative group trialsRobert S Dipaola, Ian M Thompson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Hearsay medicine is not evidence-based medicineRobert S Dipaola, Michael A Gallo
The New England Journal of Medicine|February 10, 2006
Proven and unproven therapy for benign prostatic hyperplasiaRobert S DiPaola, Ronald A Morton
Seminars in Oncology|July 19, 2003
An evidence-based approach to prostate cancer follow-upSiu-Long Yao, Robert S Dipaola
Journal of the National Cancer Institute|August 15, 2013
Our shifting understanding of factors influencing prostate-specific antigenEric A Singer, Robert S DiPaola
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
To arrest or not to G(2)-M Cell-cycle arrest : commentary re: A. K. Tyagi et al., Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G(2)-M arrest, and apoptosis. Clin. cancer res., 8: 3512-3519, 2002Robert S DiPaola
Transactions of the American Clinical and Climatological Association|August 7, 2025
LEADING A TRANSDISCIPLINARY TEAM MODEL ACROSS A COMPREHENSIVE CAMPUSRobert S Dipaola
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Clinical research in metastatic prostate cancer: a focus on impact and valueMaha Hussain, Robert S DiPaola
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
The double-edged sword of autophagy modulation in cancerEileen White, Robert S DiPaola
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Cabozantinib in prostate cancer: the beginning of a precision paradigm?Susan Goodin, Robert S DiPaola
Urology|May 12, 2005
National cooperative group trialsRobert S Dipaola, Ian M Thompson
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Hearsay medicine is not evidence-based medicineRobert S Dipaola, Michael A Gallo
The New England Journal of Medicine|February 10, 2006
Proven and unproven therapy for benign prostatic hyperplasiaRobert S DiPaola, Ronald A Morton
Seminars in Oncology|July 19, 2003
An evidence-based approach to prostate cancer follow-upSiu-Long Yao, Robert S Dipaola
Journal of the National Cancer Institute|August 15, 2013
Our shifting understanding of factors influencing prostate-specific antigenEric A Singer, Robert S DiPaola
Pageof 14